PUBLISHER: Grand View Research | PRODUCT CODE: 2151877
PUBLISHER: Grand View Research | PRODUCT CODE: 2151877
The global biopsy gun market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.3 billion in 2026 to USD 2.4 billion by 2033, at a CAGR of 9.5% from 2026 to 2033. The market in North America dominated with a revenue share of 40.5% in 2025. The market is driven by the rising incidence of cancer and other conditions requiring tissue diagnosis, increasing the need for accurate and minimally invasive biopsy procedures.
Growing adoption of image-guided biopsies, along with advances in automated biopsy guns that improve sampling precision, speed, and ease of use, is further supporting market growth. The rising incidence of cancer is driving demand for biopsy gun devices by increasing the need for timely and accurate tissue sampling for diagnosis and treatment planning. The growing number of patients with breast, prostate, liver, lung, and other cancers is contributing to higher volumes of biopsy procedures. As healthcare providers increasingly emphasize early cancer detection, the use of automated biopsy guns for obtaining adequate core tissue samples is expected to expand.
The increasing adoption of minimally invasive procedures is driving the biopsy gun market as healthcare providers seek diagnostic techniques that reduce tissue trauma, procedural discomfort, and recovery time. Biopsy guns enable the controlled collection of core tissue samples through small needle punctures, making them suitable for a wide range of image-guided procedures. The growing preference for less invasive alternatives to surgical biopsy is therefore supporting the use of automated biopsy devices across hospitals and diagnostic centers.
Furthermore, advancements in automated biopsy guns are driving the biopsy gun industry by improving the speed, precision, and consistency of tissue sample collection. Features such as automated firing mechanisms, adjustable needle penetration, improved needle design, and enhanced tissue-core retrieval can support more controlled biopsy procedures. These technological improvements are encouraging healthcare providers to adopt newer biopsy guns and replace conventional devices, supporting market growth. For instance, the ASTER biopsy gun uses a two-stage firing mechanism and adjustable penetration depths, designed to provide consistent sampling and controlled needle advancement.
Global Biopsy Gun Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biopsy gun market report on the basis of product, mechanism, application, guidance technique, end use, and region: